Staphylococcus pseudintermedius and Staphylococcus schleiferi Subspecies coagulans from Canine Pyoderma Cases in Grenada, West Indies, and Their Susceptibility to Beta-Lactam Drugs
Table 2
Antimicrobial resistance patterns of staphylococci from canine pyoderma cases in Grenada, West Indies.
Antimicrobial drug resistance
No. (%) of S. pseudintermedius ()
No. (%) of S. hominis ()
No. (%) of other staphylococcia ()
No. (%) total ()
Beta-lactamsb
Amoxicillin-clavulanic acid
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
Cefovecin
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
Cefoxitin
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
Cefpodoxime
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
Cephalothin
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
Ampicillin
1 (3.6)
0 (0.0)
0 (0.0)
1 (2.3)
Penicillin
4 (14.3)
1 (14.3)
0 (0.0)
5 (11.6)
Other drugs
Chloramphenicol
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
Enrofloxacin
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
Clindamycin
1 (3.6)
2 (33.3)
0 (0.0)
3 (7.0)
Erythromycin
1 (3.6)
2 (33.3)
0 (0.0)
3 (7.0)
Gentamicin
1 (3.6)
2 (33.3)
0 (0.0)
3 (7.0)
Neomycin
1 (3.6)
2 (33.3)
0 (0.0)
3 (7.0)
Sulfamethoxazole-trimethoprim
4 (14.3)
2 (28.6)
0 (0.0)
6 (14.0)
Tetracycline
9 (32.1)
4 (57.1)
0 (0.0)
13 (30.2)
includes the following isolates: S. lugdunensis (2); S. capitis, S. epidermidis, S. schleiferi subsp. coagulans, and S. xylosus (1 each); and unspeciated staphylococci (3).
bMethicillin resistance (tested with oxacillin disk and a chromogenic medium) was not detected in any of the S. pseudintermedius or S. schleiferi isolates.
